Literature DB >> 24494969

The relation of plasmacytoid dendritic cells (pDCs) and regulatory T-cells (Tregs) with HPV persistence in HIV-infected and HIV-uninfected women.

Howard D Strickler1, Jeffrey Martinson, Seema Desai, Xianhong Xie, Robert D Burk, Kathryn Anastos, L Stewart Massad, Howard Minkoff, Xiaonan Xue, Gypsyamber D'Souza, Alexandra M Levine, Christine Colie, D Heather Watts, Joel M Palefsky, Alan Landay.   

Abstract

Other than CD4+ count, the immunologic factors that underlie the relationship of HIV/AIDS with persistent oncogenic HPV (oncHPV) and cervical cancer are not well understood. Plasmacytoid dendritic cells (pDCs) and regulatory T-cells (Tregs) are of particular interest. pDCs have both effector and antigen presenting activity and, in HIV-positive patients, low pDC levels are associated with opportunistic infections. Tregs downregulate immune responses, and are present at high levels in HIV-positives. The current pilot study shows for the first time that low pDC and high Treg levels may be significantly associated with oncHPV persistence in both HIV-positive and HIV-negative women. Larger studies are now warranted.

Entities:  

Mesh:

Year:  2014        PMID: 24494969      PMCID: PMC3920755          DOI: 10.1089/vim.2013.0097

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  22 in total

Review 1.  Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response?

Authors:  Barbara Fazekas de St Groth; Alan L Landay
Journal:  AIDS       Date:  2008-03-30       Impact factor: 4.177

Review 2.  Host immune responses to cervical cancer.

Authors:  Swati Patel; Shubhada Chiplunkar
Journal:  Curr Opin Obstet Gynecol       Date:  2009-02       Impact factor: 1.927

Review 3.  Natural type 1 interferon producing cells in HIV infection.

Authors:  Vassili Soumelis; Iain Scott; Yong-Jun Liu; Jay Levy
Journal:  Hum Immunol       Date:  2002-12       Impact factor: 2.850

4.  Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity.

Authors:  F P Siegal; C Lopez; P A Fitzgerald; K Shah; P Baron; I Z Leiderman; D Imperato; S Landesman
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

5.  Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells.

Authors:  Petra Lenz; Douglas R Lowy; John T Schiller
Journal:  Eur J Immunol       Date:  2005-05       Impact factor: 5.532

6.  PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems.

Authors:  W Qu; G Jiang; Y Cruz; C J Chang; G Y Ho; R S Klein; R D Burk
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

7.  Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.

Authors:  Howard D Strickler; Robert D Burk; Melissa Fazzari; Kathryn Anastos; Howard Minkoff; L Stewart Massad; Charles Hall; Melanie Bacon; Alexandra M Levine; D Heather Watts; Michael J Silverberg; Xiaonan Xue; Nicolas F Schlecht; Sandra Melnick; Joel M Palefsky
Journal:  J Natl Cancer Inst       Date:  2005-04-20       Impact factor: 13.506

8.  Diminished IFN-gamma and IL-10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3.

Authors:  Mark E Scott; Yifei Ma; Lili Kuzmich; Anna-Barbara Moscicki
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

9.  Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.

Authors:  Linda Ahdieh-Grant; Rui Li; Alexandra M Levine; L Stewart Massad; Howard D Strickler; Howard Minkoff; Michael Moxley; Joel Palefsky; Henry Sacks; Robert D Burk; Stephen J Gange
Journal:  J Natl Cancer Inst       Date:  2004-07-21       Impact factor: 13.506

10.  CD4(+)CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia.

Authors:  Johan W Molling; Tanja D de Gruijl; Judith Glim; Maria Moreno; Lawrence Rozendaal; Chris J L M Meijer; Alfons J M van den Eertwegh; Rik J Scheper; Mary E von Blomberg; Hetty J Bontkes
Journal:  Int J Cancer       Date:  2007-10-15       Impact factor: 7.396

View more
  9 in total

1.  Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV+ Cancers.

Authors:  Gabriele Galliverti; Stephan Wullschleger; Mélanie Tichet; Dhaarini Murugan; Nadine Zangger; Wesley Horton; Alan J Korman; Lisa M Coussens; Melody A Swartz; Douglas Hanahan
Journal:  Cancer Immunol Res       Date:  2019-11-26       Impact factor: 11.151

2.  Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer.

Authors:  Dan Song; Hong Li; Haibo Li; Jianrong Dai
Journal:  Oncol Lett       Date:  2015-05-29       Impact factor: 2.967

3.  Twelve-Year Trend in the Prevalence of High-Risk Human Papillomavirus Infection Among Rwandan Women Living With HIV.

Authors:  Gad Murenzi; Faustin Kanyabwisha; Anthere Murangwa; Gallican Kubwimana; Leon Mutesa; Robert D Burk; Kathryn Anastos; Philip E Castle
Journal:  J Infect Dis       Date:  2020-06-16       Impact factor: 5.226

Review 4.  CD4 T Cells Mediate Both Positive and Negative Regulation of the Immune Response to HIV Infection: Complex Role of T Follicular Helper Cells and Regulatory T Cells in Pathogenesis.

Authors:  Chansavath Phetsouphanh; Yin Xu; John Zaunders
Journal:  Front Immunol       Date:  2015-01-06       Impact factor: 7.561

5.  Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta-analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status.

Authors:  Katharine J Looker; Minttu M Rönn; Patrick M Brock; Marc Brisson; Melanie Drolet; Philippe Mayaud; Marie-Claude Boily
Journal:  J Int AIDS Soc       Date:  2018-06       Impact factor: 5.396

6.  Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE.

Authors:  Kristina Thorsteinsson; Steen Ladelund; Merete Storgaard; Terese L Katzenstein; Isik Somuncu Johansen; Gitte Pedersen; Frederikke Falkencrone Rönsholt; Lars Nørregård Nielsen; Lisbeth Nilas; Maria Franzmann; Niels Obel; Anne-Mette Lebech; Jesper Bonde
Journal:  BMC Infect Dis       Date:  2019-08-22       Impact factor: 3.090

7.  Longitudinal assessment of abnormal Papanicolaou test rates among women with HIV.

Authors:  Leslie S Massad; Xianhong Xie; Howard Minkoff; Seble Kassaye; Roksana Karim; Teresa M Darragh; Elizabeth T Golub; Adaora Adimora; Gina Wingood; Margaret Fischl; Deborah Konkle-Parker; Howard D Strickler
Journal:  AIDS       Date:  2020-01-01       Impact factor: 4.632

8.  Candidate Soluble Immune Mediators in Young Women with High-Risk Human Papillomavirus Infection: High Expression of Chemokines Promoting Angiogenesis and Cell Proliferation.

Authors:  Nunzia Zanotta; Maria Lina Tornesello; Clorinda Annunziata; Giovanni Stellato; Franco Maria Buonaguro; Manola Comar
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

9.  Genetic variant in CXCL12 gene raises susceptibility to HPV infection and squamous intraepithelial lesions development: a case-control study.

Authors:  Nádia Calvo Martins Okuyama; Fernando Cezar-Dos-Santos; Érica Romão Pereira; Kleber Paiva Trugilo; Guilherme Cesar Martelossi Cebinelli; Michelle Mota Sena; Ana Paula Lombardi Pereira; Adriano Martin Felis Aranome; Luis Fernando Lasaro Mangieri; Rodolfo Sanches Ferreira; Maria Angelica Ehara Watanabe; Karen Brajão de Oliveira
Journal:  J Biomed Sci       Date:  2018-09-18       Impact factor: 8.410

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.